Eric Pauwels's most recent trade in PTC Therapeutics Inc was a trade of 3,019 Common Stock done at an average price of $69.4 . Disclosure was reported to the exchange on Feb. 18, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 69.36 per share. | 18 Feb 2026 | 3,019 | 77,122 (0%) | 0% | 69.4 | 209,398 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 76.42 per share. | 08 Jan 2026 | 2,561 | 84,928 (0%) | 0% | 76.4 | 195,712 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 77.41 per share. | 08 Jan 2026 | 1,722 | 81,165 (0%) | 0% | 77.4 | 133,300 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 76.45 per share. | 08 Jan 2026 | 1,454 | 82,887 (0%) | 0% | 76.4 | 111,158 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 78.70 per share. | 08 Jan 2026 | 1,024 | 80,141 (0%) | 0% | 78.7 | 80,589 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 76.98 per share. | 08 Jan 2026 | 587 | 84,341 (0%) | 0% | 77.0 | 45,187 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 76.95 per share. | 06 Jan 2026 | 1,789 | 88,841 (0%) | 0% | 77.0 | 137,664 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 77.48 per share. | 06 Jan 2026 | 1,352 | 87,489 (0%) | 0% | 77.5 | 104,753 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 20,000 | 90,630 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.49 per share. | 19 Dec 2025 | 19,805 | 90,178 (0%) | 0% | 66.5 | 1,316,834 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 19,805 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 77.55 per share. | 19 Dec 2025 | 10,548 | 73,593 (0%) | 0% | 77.5 | 817,997 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 76.33 per share. | 19 Dec 2025 | 4,537 | 84,141 (0%) | 0% | 76.3 | 346,309 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 78.33 per share. | 19 Dec 2025 | 3,220 | 70,373 (0%) | 0% | 78.3 | 252,223 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 75.77 per share. | 19 Dec 2025 | 1,500 | 88,678 (0%) | 0% | 75.8 | 113,655 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.01 per share. | 19 Dec 2025 | 565 | 70,938 (0%) | 0% | 18.0 | 10,176 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 565 | 17,566 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 77.73 per share. | 19 Dec 2025 | 313 | 70,432 (0%) | 0% | 77.7 | 24,329 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 75.45 per share. | 19 Dec 2025 | 193 | 70,745 (0%) | 0% | 75.5 | 14,562 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.49 per share. | 19 Dec 2025 | 138 | 70,511 (0%) | 0% | 66.5 | 9,176 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 Dec 2025 | 138 | 19,805 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 78.42 per share. | 19 Dec 2025 | 59 | 70,373 (0%) | 0% | 78.4 | 4,627 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 78.02 per share. | 19 Dec 2025 | 59 | 70,373 (0%) | 0% | 78.0 | 4,603 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 77.26 per share. | 19 Dec 2025 | 42 | 70,432 (0%) | 0% | 77.3 | 3,245 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 75.65 per share. | 19 Dec 2025 | 37 | 70,474 (0%) | 0% | 75.6 | 2,799 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 36,606 | 22,894 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.49 per share. | 17 Dec 2025 | 35,361 | 105,734 (0%) | 0% | 66.5 | 2,351,153 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 75.44 per share. | 17 Dec 2025 | 35,261 | 70,473 (0%) | 0% | 75.4 | 2,660,090 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.01 per share. | 17 Dec 2025 | 3,684 | 74,157 (0%) | 0% | 18.0 | 66,349 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 3,684 | 18,382 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 75.31 per share. | 17 Dec 2025 | 3,584 | 70,473 (0%) | 0% | 75.3 | 269,911 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 2,951 | 19,943 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.49 per share. | 17 Dec 2025 | 2,831 | 73,204 (0%) | 0% | 66.5 | 188,233 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 75.07 per share. | 17 Dec 2025 | 2,831 | 70,373 (0%) | 0% | 75.1 | 212,523 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 75.28 per share. | 17 Dec 2025 | 1,245 | 72,912 (0%) | 0% | 75.3 | 93,724 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.49 per share. | 17 Dec 2025 | 1,245 | 74,157 (0%) | 0% | 66.5 | 82,780 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 75.00 per share. | 17 Dec 2025 | 251 | 70,373 (0%) | 0% | 75 | 18,825 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.01 per share. | 17 Dec 2025 | 251 | 70,624 (0%) | 0% | 18.0 | 4,521 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Dec 2025 | 251 | 18,131 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 75.02 per share. | 17 Dec 2025 | 120 | 70,373 (0%) | 0% | 75.0 | 9,002 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 66.49 per share. | 17 Dec 2025 | 120 | 70,493 (0%) | 0% | 66.5 | 7,979 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 76.00 per share. | 17 Dec 2025 | 100 | 70,373 (0%) | 0% | 76 | 7,600 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 76.00 per share. | 17 Dec 2025 | 100 | 70,373 (0%) | 0% | 76 | 7,600 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.86 per share. | 08 Sep 2025 | 16,698 | 89,610 (0%) | 0% | 30.9 | 515,300 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2025 | 16,698 | 3,713 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 56.94 per share. | 08 Sep 2025 | 16,698 | 72,912 (0%) | 0% | 56.9 | 950,784 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2025 | 8,528 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 56.92 per share. | 08 Sep 2025 | 8,528 | 72,912 (0%) | 0% | 56.9 | 485,414 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.01 per share. | 08 Sep 2025 | 8,528 | 81,440 (0%) | 0% | 18.0 | 153,589 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2025 | 6,017 | 2,406 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 56.91 per share. | 08 Sep 2025 | 6,017 | 72,912 (0%) | 0% | 56.9 | 342,427 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.23 per share. | 08 Sep 2025 | 6,017 | 78,929 (0%) | 0% | 11.2 | 67,571 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2025 | 3,713 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 56.92 per share. | 08 Sep 2025 | 3,713 | 72,912 (0%) | 0% | 56.9 | 211,344 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.86 per share. | 08 Sep 2025 | 3,713 | 76,625 (0%) | 0% | 30.9 | 114,583 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2025 | 2,406 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 56.92 per share. | 08 Sep 2025 | 2,406 | 72,912 (0%) | 0% | 56.9 | 136,950 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.23 per share. | 08 Sep 2025 | 2,406 | 75,318 (0%) | 0% | 11.2 | 27,019 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2025 | 1,250 | 0 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 56.86 per share. | 08 Sep 2025 | 1,250 | 72,912 (0%) | 0% | 56.9 | 71,075 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.32 per share. | 08 Sep 2025 | 1,250 | 74,162 (0%) | 0% | 11.3 | 14,150 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2025 | 1,238 | 1,250 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 56.85 per share. | 08 Sep 2025 | 1,238 | 72,912 (0%) | 0% | 56.8 | 70,380 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 11.32 per share. | 08 Sep 2025 | 1,238 | 74,150 (0%) | 0% | 11.3 | 14,014 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 55.19 per share. | 14 Mar 2025 | 4,458 | 79,402 (0%) | 0% | 55.2 | 246,037 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 57.67 per share. | 14 Mar 2025 | 3,340 | 72,940 (0%) | 0% | 57.7 | 192,618 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 55.24 per share. | 14 Mar 2025 | 2,037 | 77,365 (0%) | 0% | 55.2 | 112,524 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 56.62 per share. | 14 Mar 2025 | 1,085 | 76,280 (0%) | 0% | 56.6 | 61,433 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 58.31 per share. | 14 Mar 2025 | 300 | 72,640 (0%) | 0% | 58.3 | 17,493 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 50.12 per share. | 19 Feb 2025 | 1,567 | 83,860 (0%) | 0% | 50.1 | 78,544 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 50.10 per share. | 19 Feb 2025 | 1,378 | 85,427 (0%) | 0% | 50.1 | 69,032 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 44.50 per share. | 07 Jan 2025 | 2,136 | 86,805 (0%) | 0% | 44.5 | 95,052 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 45.34 per share. | 07 Jan 2025 | 1,599 | 88,941 (0%) | 0% | 45.3 | 72,499 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2025 | 22,000 | 90,540 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Eric Pauwels | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 25.13 per share. | 17 Apr 2024 | 787 | 67,694 (0%) | 0% | 25.1 | 19,781 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 22,000 | 66,181 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Pauwels Eric | CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 2,300 | 68,481 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 27.25 per share. | 30 Jan 2024 | 366 | 44,181 (0%) | 0% | 27.3 | 9,974 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 29.02 per share. | 08 Jan 2024 | 2,065 | 44,547 (0%) | 0% | 29.0 | 59,916 | Common Stock |
| PTC Therapeutics Inc | Pauwels Eric | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 28.64 per share. | 08 Jan 2024 | 1,569 | 46,612 (0%) | 0% | 28.6 | 44,937 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 58.96 per share. | 19 May 2023 | 6,403 | 49,566 (0%) | 0% | 59.0 | 377,491 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 58.98 per share. | 19 May 2023 | 1,913 | 47,653 (0%) | 0% | 59.0 | 112,825 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 59.66 per share. | 19 May 2023 | 100 | 47,553 (0%) | 0% | 59.7 | 5,966 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 58.50 per share. | 17 May 2023 | 7,248 | 56,757 (0%) | 0% | 58.5 | 424,008 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 58.52 per share. | 17 May 2023 | 800 | 64,005 (0%) | 0% | 58.5 | 46,814 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 58.71 per share. | 17 May 2023 | 788 | 55,969 (0%) | 0% | 58.7 | 46,267 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 52.04 per share. | 18 Apr 2023 | 732 | 64,805 (0%) | 0% | 52.0 | 38,096 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 45.63 per share. | 31 Jan 2023 | 375 | 65,537 (0%) | 0% | 45.6 | 17,111 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 47.45 per share. | 24 Jan 2023 | 359 | 65,912 (0%) | 0% | 47.5 | 17,035 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 42.93 per share. | 10 Jan 2023 | 663 | 66,842 (0%) | 0% | 42.9 | 28,465 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 44.36 per share. | 10 Jan 2023 | 571 | 66,271 (0%) | 0% | 44.4 | 25,329 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 41.66 per share. | 09 Jan 2023 | 858 | 67,505 (0%) | 0% | 41.7 | 35,741 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 45,000 | 45,000 | - | - | Stock Option (Right to Buy) | |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 18,000 | 68,363 (0%) | 0% | 0 | Common Stock | |
| PTC Therapeutics Inc | Eric Pauwels | CHIEF BUSINESS OFFICER | Sale of securities on an exchange or to another person at price $ 42.51 per share. | 19 Apr 2022 | 822 | 49,772 (0%) | 0% | 42.5 | 34,947 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 01 Feb 2022 | 367 | 50,594 (0%) | 0% | 40.0 | 14,681 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | Chief Business Officer | Sale of securities on an exchange or to another person at price $ 39.31 per share. | 25 Jan 2022 | 359 | 50,961 (0%) | 0% | 39.3 | 14,114 | Common Stock |
| PTC Therapeutics Inc | Eric Pauwels | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 63,000 | 63,000 | - | - | Stock Option (Right to Buy) |